Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0622

William B. Slayton(BC Children's Hospital), Stephen P. Hunger(Children's Hospital of Philadelphia), Julie M. Gastier‐Foster(Nationwide Children's Hospital), Thomas E. Merchant(St. Jude Children's Research Hospital), Mignon L. Loh(Seattle Children's Hospital), Brent L. Wood(University of Southern California), Bill H. Chang(Oregon Health & Science University), Elizabeth A. Raetz(NYU Langone Health), John A. Kairalla(BC Children's Hospital), Charles G. Mullighan(St. Jude Children's Research Hospital), Lewis B. Silverman(Columbia University Irving Medical Center), Xinlei Mi(BC Children's Hospital), Naomi Winick(The University of Texas Southwestern Medical Center), Ilaria Iacobucci(St. Jude Children's Research Hospital), Kirk R. Schultz(University of British Columbia), Andrew J. Carroll(University of Alabama at Birmingham), Lance Sieger(BC Children's Hospital), William L. Carroll(NYU Langone Health), Valerie I. Brown(BC Children's Hospital), Meenakshi Devidas(National Institutes of Health), Sherri L. Mizrahy(BC Children's Hospital), Michael J. Borowitz(Johns Hopkins University), Marilyn J. Siegel(Mallinckrodt (United States)), Nyla A. Heerema(The Ohio State University), Michael A. Pulsipher(Primary Children's Hospital)
Journal of Clinical Oncology
May 29, 2018
Cited by 249


Related Papers